RK 33 is a small molecule inhibitor of the DEAD-box RNA helicase DDX3, currently under investigation for its potential in oncology and related therapeutic areas. Researchers utilize high-quality reference… Read more
RK 33 is a small molecule inhibitor of the DEAD-box RNA helicase DDX3, currently under investigation for its potential in oncology and related therapeutic areas. Researchers utilize high-quality reference standards of this compound to support analytical method development and impurity profiling in both preclinical and pharmaceutical studies. The category includes stable isotope labelled compounds such as RK 33-d6, which are critical for mass spectrometry-based assays. These deuterium-labelled internal standards act as vital analytical tools to ensure precise quantification by correcting for matrix effects and variations during sample preparation. By providing access to the parent compound and its related synthetic analogues, these reference materials facilitate rigorous quality control and the validation of bioanalytical methods, enabling scientists to accurately monitor drug concentrations and degradation products throughout the lifecycle of drug development.